Literature DB >> 6639109

Therapy for basal cell epitheliomas by curettage only. Further study.

W E McDaniel.   

Abstract

Thorough curettage alone, a simple, effective, inexpensive therapy, has now been used to treat 644 basal cell epitheliomas in 437 patients. Three hundred twenty-eight treatment sites have been evaluated for more than five years. There have been 28 recurrences. Cosmetic results are superior to those obtained with x-ray therapy and electrocoagulation, and appear to be at least equal to those following cryosurgery and excision surgery.

Entities:  

Mesh:

Year:  1983        PMID: 6639109

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

Review 1.  Diagnosis and Management of Basal Cell Carcinoma.

Authors:  Keiji Tanese
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

2.  Nonsurgical Options for the Treatment of Basal Cell Carcinoma.

Authors:  John Paoli; Johan Dahlén Gyllencreutz; Julia Fougelberg; Eva Johansson Backman; Maja Modin; Sam Polesie; Oscar Zaar
Journal:  Dermatol Pract Concept       Date:  2019-04-30

3.  Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy.

Authors:  Eidi Christensen; Cato Mørk; Olav Andreas Foss
Journal:  J Skin Cancer       Date:  2011-11-15

4.  Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial.

Authors:  E J Backman; S Polesie; S Berglund; M Gillstedt; A Sjöholm; M Modin; J Paoli
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-21       Impact factor: 9.228

Review 5.  Updates on the Management of Non-Melanoma Skin Cancer (NMSC).

Authors:  Artur Fahradyan; Anna C Howell; Erik M Wolfswinkel; Michaela Tsuha; Parthiv Sheth; Alex K Wong
Journal:  Healthcare (Basel)       Date:  2017-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.